Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Crichton

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|January 6, 2017
Paternalism v. autonomyPaul Crichton
Bjpsych Bulletin|April 13, 2017
Epistemic injustice in psychiatryPaul Crichton, Havi Carel, Ian James Kidd
Journal of Glaucoma|May 6, 2021
Analysis of Efficacy and Safety of Pediatric Ahmed Glaucoma Valve (FP8) in Advanced Age PopulationsPaul Crichton, Emi Sanders, Gavin Docherty, et al.
Psychiatric Bulletin (London, England)|November 1, 1992
Are psychiatric case-notes offensive?Paul Crichton, Athanassios Douzenis, Claire Leggatt, et al.
American Journal of Ophthalmology|December 29, 2022
AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide TherapyYi Zhai, Manlong Xu, Alina Radziwon, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The British Journal of Psychiatry : the Journal of Mental Science|January 6, 2017
Paternalism v. autonomyPaul Crichton
Bjpsych Bulletin|April 13, 2017
Epistemic injustice in psychiatryPaul Crichton, Havi Carel, Ian James Kidd
Journal of Glaucoma|May 6, 2021
Analysis of Efficacy and Safety of Pediatric Ahmed Glaucoma Valve (FP8) in Advanced Age PopulationsPaul Crichton, Emi Sanders, Gavin Docherty, et al.
Psychiatric Bulletin (London, England)|November 1, 1992
Are psychiatric case-notes offensive?Paul Crichton, Athanassios Douzenis, Claire Leggatt, et al.
American Journal of Ophthalmology|December 29, 2022
AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide TherapyYi Zhai, Manlong Xu, Alina Radziwon, et al.
Pageof 1